MarketPeel
Insider Trading Intelligence
BL

Bios Equity Partners Iii, Lp

INAB
DIRECTOR · IN8BIO, INC. · CIK 0001831976
FILING MIX · LIFETIME66%/34%
BUYS
109
SELLS
55
TOTAL VALUE
$17.97M
COMPANIES
4
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
649,695
AVG SELL PX
$8.50
TRADE KIND
SHOWING 164 / 164
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
39 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Bios Equity Partners Iii, Lp, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d39+58.97%+3.97%-0.50%+4.48%+3.23%1.65
14d39+66.67%+21.48%-0.24%+21.72%+2.76%2.78
30d39+58.97%+13.97%-1.74%+15.70%+4.57%2.45
60d39+35.90%-10.28%-0.77%-9.51%-8.63%-1.47
90d39+28.21%-22.59%+1.77%-24.36%-21.47%-5.04
180d39+35.90%-22.98%+5.82%-28.80%-23.06%-4.85
1y39+7.69%-59.34%+17.62%-76.96%-64.61%-14.72
2y39(3 pending)+8.33%-81.44%+44.97%-126.42%-129.26%-46.13
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
INAB · 0 shares · as of May 2, 2025
0931,8991,863,7992,795,6983,727,5972022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 109 buys / 55 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
71,42871,428Jun 27, 2025Jun 30, 2025View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
71,428$7.00$500.0K196,428Jun 27, 2025Jun 30, 2025View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
34,00048,500Jun 18, 2025Jun 20, 2025View →
INAB
IN8BIO, INC.
SALE
574,2410May 2, 2025May 7, 2025View →
INAB
IN8BIO, INC.
PURCHASE
1,148,4822,431,763May 2, 2025May 7, 2025View →
INAB
IN8BIO, INC.
SALE
574,2410May 2, 2025May 7, 2025View →
INAB
IN8BIO, INC.
PURCHASE
709,040709,040Oct 4, 2024Oct 11, 2024View →
INAB
IN8BIO, INC.
PURCHASEGRANT
Stock grant
574,241574,241Oct 4, 2024Oct 11, 2024View →
INAB
IN8BIO, INC.
PURCHASE
709,0401,283,281Oct 4, 2024Oct 11, 2024View →
INAB
IN8BIO, INC.
PURCHASE
574,2410Oct 4, 2024Oct 11, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
307,5380Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
332,8670Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
44,5590Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,022,0290Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
326,5470Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
74,202383,791Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
2,022,0292,022,029Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
61,8570Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
309,5890Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
153,702153,702Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
147,047300,749Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
484,6380Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
61,85761,857Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
462,073462,073Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
573,3940Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
573,394573,394Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
74,2020Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
141,457141,457Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
307,538307,538Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
26,355$5.27$138.9K997,794Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
309,589309,589Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
176,499638,572Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
8,0680Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
44,559130,044Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
2,094,6502,094,650Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
153,7020Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
23,6280Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
78,2670Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
884,427884,427Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
484,6382,506,667Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
525,7970Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,324$9.00$20.9K131,248Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
8,068$5.27$42.5K305,457Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
147,0470Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,094,6500Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
5,314$9.00$47.8K300,143Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
525,797525,797Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
23,62885,485Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
3,528$5.27$18.6K133,572Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
141,4570Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
884,4270Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
326,547326,547Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
125,000$8.00$1.00M125,000Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
332,867971,439Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
54,0320Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
101,900297,389Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
462,0730Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
54,032195,489Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
78,267404,814Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
101,9000Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASE
375,000$8.00$3.00M1,259,427Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
26,3550Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
3,5280Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
176,4990Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
17,361$9.00$156.2K980,433Aug 14, 2024Aug 14, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
17,361$8.00$138.9K980,433Aug 14, 2024Aug 20, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
2,324$8.00$18.6K131,248Aug 14, 2024Aug 20, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
SALE
5,314$8.00$42.5K300,143Aug 14, 2024Aug 20, 2024View →
ACTU
ACTUATE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,00015,000Aug 12, 2024Aug 14, 2024View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,5008,500Jun 7, 2024Jun 11, 2024View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,50014,500Jun 7, 2024Jun 11, 2024View →
INAB
IN8BIO, INC.
PURCHASE
574,241574,241Dec 13, 2023Dec 14, 2023View →
INAB
IN8BIO, INC.
PURCHASE
574,241574,241Dec 13, 2023Dec 14, 2023View →
INAB
IN8BIO, INC.
PURCHASE
574,241574,241Dec 13, 2023Dec 14, 2023View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
500,095$1.05$525.1K500,095Nov 8, 2023Nov 13, 2023View →
AZTR
AZITRA, INC.
PURCHASE
111,720111,720Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
25,280137,000Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
436,173436,173Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
52,0780Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
77,9530Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
208,531208,531Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
808,0580Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
197,701197,701Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
144,705426,944Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
123,7180Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
1,291,2581,291,258Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
467,613467,613Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
170,2720Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
896,0352,643,705Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
188,8101,023,442Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
22,7980Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
69,880$5.00$349.4K267,581Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
799,467799,467Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
73,708$5.00$368.5K282,239Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
456,412$5.00$2.28M1,747,670Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
101,8420Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
799,4670Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
467,6130Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
509,1410Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
57,747313,250Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
130,4980Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
412,3890Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
255,503255,503Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
232,9080Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
82,2230Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
SALE
397,6000Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
834,632834,632Jun 21, 2023Jun 23, 2023View →
AZTR
AZITRA, INC.
PURCHASE
137,186404,767Jun 21, 2023Jun 23, 2023View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
6,0006,000Jun 9, 2023Jun 13, 2023View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASEGRANT
Stock grant
6,0006,000Jun 9, 2023Jun 13, 2023View →
INAB
IN8BIO, INC.
PURCHASE
8,735$2.48$21.7K570,724Dec 12, 2022Dec 13, 2022View →
INAB
IN8BIO, INC.
PURCHASE
57,052$2.48$141.4K3,727,597Dec 12, 2022Dec 13, 2022View →
INAB
IN8BIO, INC.
PURCHASE
9,214$2.48$22.8K601,980Dec 12, 2022Dec 13, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
1,973$2.65$5.2K326,733Nov 28, 2022Nov 29, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
12,220$2.65$32.4K2,021,906Nov 28, 2022Nov 29, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
1,871$2.65$5.0K309,748Nov 28, 2022Nov 29, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
8,269$1.40$11.6K307,877Nov 16, 2022Nov 17, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
8,722$1.40$12.2K324,760Nov 16, 2022Nov 17, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
54,009$1.40$75.6K2,009,686Nov 16, 2022Nov 17, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
174,700$1.20$209.6K299,608Nov 15, 2022Nov 16, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
184,270$1.20$221.1K316,038Nov 15, 2022Nov 16, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
1,141,030$1.20$1.37M1,955,677Nov 15, 2022Nov 16, 2022View →
INAB
IN8BIO, INC.
PURCHASE
19,017$2.02$38.4K3,670,545Sep 28, 2022Sep 29, 2022View →
INAB
IN8BIO, INC.
PURCHASE
2,913$2.02$5.9K561,989Sep 28, 2022Sep 29, 2022View →
INAB
IN8BIO, INC.
PURCHASE
3,070$2.02$6.2K592,766Sep 28, 2022Sep 29, 2022View →
INAB
IN8BIO, INC.
PURCHASE
30,428$2.02$61.5K3,651,528Aug 29, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
4,912$2.02$9.9K589,696Aug 29, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
4,660$2.02$9.4K559,076Aug 29, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
4,660$2.02$9.4K559,076Aug 29, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
30,428$2.02$61.5K3,651,528Aug 29, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
4,912$2.02$9.9K589,696Aug 29, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
8,531$2.01$17.1K3,621,100Aug 26, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
1,306$2.01$2.6K554,416Aug 26, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
1,377$2.01$2.8K584,784Aug 26, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
1,377$2.01$2.8K584,784Aug 26, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
1,306$2.01$2.6K554,416Aug 26, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
8,531$2.01$17.1K3,621,100Aug 26, 2022Aug 30, 2022View →
INAB
IN8BIO, INC.
PURCHASE
5,823$1.93$11.2K553,110Aug 17, 2022Aug 17, 2022View →
INAB
IN8BIO, INC.
PURCHASE
6,142$1.93$11.9K583,407Aug 17, 2022Aug 17, 2022View →
INAB
IN8BIO, INC.
PURCHASE
38,035$1.93$73.4K3,612,569Aug 17, 2022Aug 17, 2022View →
INAB
IN8BIO, INC.
PURCHASE
38,035$1.93$73.4K3,612,569Aug 17, 2022Aug 17, 2022View →
INAB
IN8BIO, INC.
PURCHASE
6,142$1.93$11.9K583,407Aug 17, 2022Aug 17, 2022View →
INAB
IN8BIO, INC.
PURCHASE
5,823$1.93$11.2K553,110Aug 17, 2022Aug 17, 2022View →
INAB
IN8BIO, INC.
PURCHASE
206,575$1.90$392.5K540,287Aug 16, 2022Aug 16, 2022View →
INAB
IN8BIO, INC.
PURCHASE
1,349,218$1.90$2.56M3,574,534Aug 16, 2022Aug 16, 2022View →
INAB
IN8BIO, INC.
PURCHASE
217,891$1.90$414.0K217,891Aug 16, 2022Aug 16, 2022View →
INAB
IN8BIO, INC.
PURCHASE
206,575$1.90$392.5K540,287Aug 16, 2022Aug 16, 2022View →
INAB
IN8BIO, INC.
PURCHASE
217,891$1.90$414.0K217,891Aug 16, 2022Aug 16, 2022View →
INAB
IN8BIO, INC.
PURCHASE
1,349,218$1.90$2.56M3,574,534Aug 16, 2022Aug 16, 2022View →
CGTX
COGNITION THERAPEUTICS INC
PURCHASE
1,424,0141,424,014Oct 13, 2021Jan 31, 2022View →
INAB
IN8BIO, INC.
SALE
309,8230Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
SALE
522,3550Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
SALE
228,4380Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
SALE
1,706,4900Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
PURCHASE
574,432574,432Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
SALE
907,0070Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
PURCHASE
251,211251,211Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
SALE
2,023,5680Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
PURCHASE
340,712340,712Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
PURCHASE
2,225,3162,225,316Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
SALE
326,7950Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
PURCHASE
1,876,6241,876,624Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
PURCHASE
359,374359,374Aug 3, 2021Aug 3, 2021View →
INAB
IN8BIO, INC.
PURCHASE
997,433997,433Aug 3, 2021Aug 3, 2021View →
Other insiders · INAB
Loading peer insiders…
About this filer
CIK 0001831976
ROLE
Director
PRIMARY
INAB
COMPANIES
4
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001831976DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback